RGC logo

REGENCELL BIOSCIENCE HOLDING

RGCNASDAQ
πŸ† #1495 by market capUS Equity
$6.86β–Ό $0.45 (βˆ’6.16%)
After hours Β· at close
πŸ””
Track RGC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 6.2%
7dβ–Ό 30.4%
14dβ–Ό 26.5%
30dβ–² 10.7%
ytdβ–Ό 67.5%
1yβ–Ό 59.0%
🏦Market Cap
$3.40B
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$6.82 – $7.19
52-Week Range
$4.51 – $69.00
Volume (shares)
5,152
Avg Volume (shares)
β€”
Shares Outstanding
495.9M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
$-0.02
Dividend Yield
β€”
Dilution (1yr)
+0.0%
RGC logo

REGENCELL BIOSCIENCE HOLDING

RGC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$12Mβ–² +211.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$8Mβ–² +135.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
494.7Mβ–² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$14Mβ–² +$12M YoY
StockOtter Β· stockotter.space

About REGENCELL BIOSCIENCE HOLDING

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.